About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT07390370

Establishment of a Registry for Immediate Drug Allergy

Immediate drug hypersensitivity reactions are acute adverse reactions that occur within one hour of drug administration and can result in life-threatening symptoms such as urticaria, angioedema, and a...

Lead sponsor: Yonsei University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Kyung Hee Park, P

CONTACT

+82-2-2228-1947 [email protected]

Sponsors

Lead Sponsor

Yonsei University

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Adult patients aged 19 years or older diagnosed with immediate hypersensitivity reactions (such as rash, urticaria, angioedema, anaphylaxis, etc.) within 1 hour after drug administration."
•2. Utilization of samples and clinical data from patients with immediate drug hypersensitivity who consented to participate in secondary research, registered in the study 'Establishment of a Registry for Identifying Factors Related to Diagnosis, Treatment, and Prognosis in Allergic Disease Patients' (Project Number 4-2013-0397).

Exclusion Criteria

•1. Participants who do not consent to participate in the study."
•2. Children and adolescents under the age of 19."
•3. Participants who are unable to read or understand the consent form."

Related studies

RECRUITINGPhase 2

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

NCT06406114 · Drug Allergy, Cephalosporin Allergy, and more

Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

NCT07069439 · Drug Hypersensitivity, Quality of Life (QOL), and more

Optimal Doses for Drug Provocation Tests to Beta-lactams

NCT02839551 · Drug Hypersensitivity

Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire

NCT06523192 · Drug Hypersensitivity, Quality of Life

A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults

NCT05269082 · Drug Hypersensitivity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 5, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment200

Start dateFeb 2026

Last updatedFeb 5, 2026

Condition

Drug Hypersensitivity

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 5, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions